EMA Committee for Medicinal Products for Human Use
The Committee for Medicinal Products for Human Use (CHMP) is a key body within the EMA responsible for evaluating centralised marketing authorisation applications.
It issues scientific opinions on the quality, efficacy, and safety of medicines for human use. Its recommendations form the basis for European Commission decisions to grant or refuse marketing authorisation.
The CHMP is one of the most influential committees in European pharmaceutical regulation.
